Abridge partners with Eli Lilly, Nvidia as AI scribe eyes expansion

The company is working with Nvidia to build a foundation model for clinical conversations, and it scored a strategic investment from drugmaker Eli Lilly, Abridge announced during a sweeping keynote Thursday.